What Mini-ACE cutoff is commonly used for cognitive impairment?

A score of 25 or lower (out of 30) is the most widely used threshold for possible cognitive impairment, with published sensitivity of 88% and specificity of 89% for dementia. Higher cutoffs (26-27) improve sensitivity at the cost of specificity.

How long does Mini-ACE take to administer?

Mini-ACE takes approximately 5 minutes, making it one of the fastest validated multidomain cognitive screens available. This compares favorably to MMSE (7-10 min) and MoCA (10-15 min) when time is limited.

Who developed the Mini-ACE?

The Mini-ACE was formally described and validated by O'Driscoll and Ridha (2017) in the UK, although earlier abbreviated ACE forms were described by Hsieh and colleagues. It is derived from the Addenbrooke's Cognitive Examination (ACE-III) developed at Cambridge.

What cognitive domains does Mini-ACE test?

Mini-ACE tests five domains: orientation and immediate recall (memory encoding), verbal fluency (executive function and semantic memory), visuospatial ability via clock drawing, and delayed recall. This multidomain sampling provides a more comprehensive cognitive profile than MMSE.

Can Mini-ACE diagnose dementia?

No. Mini-ACE is a screening tool that identifies patients likely to have cognitive impairment. Formal dementia diagnosis requires comprehensive clinical assessment including history from patient and informant, functional assessment, neuroimaging, laboratory tests, and specialist review.

How does Mini-ACE compare to MMSE?

Mini-ACE samples a broader range of cognitive domains including executive function (fluency) and visuospatial ability, which MMSE does not adequately cover. Mini-ACE has better sensitivity for detecting early dementia, particularly frontal and visuospatial presentations, compared to MMSE.

How does Mini-ACE differ from the full ACE-III?

The full ACE-III is a 100-point instrument covering attention, memory, fluency, language, and visuospatial domains in detail. Mini-ACE is a 5-item, 30-point abbreviation designed for rapid screening. A positive Mini-ACE screen ideally triggers full ACE-III or neuropsychological evaluation.

Is Mini-ACE suitable for monitoring cognitive decline over time?

Yes. Mini-ACE can be used serially at 6-12 month intervals to monitor cognitive trajectory. Declining scores over time—even within the normal range—are clinically significant and support progressive impairment. Baseline documentation is essential.

Does education level affect Mini-ACE scores?

Yes. Verbal fluency scores and some memory items correlate with educational attainment. Clinicians should apply caution when interpreting scores from patients with fewer than 8 years of formal education. In highly educated patients, a score of 25 may still indicate early impairment.

Can Mini-ACE be used in patients with depression?

Depression can cause pseudodementia that lowers Mini-ACE scores. Always screen for depression (e.g., GDS-5) when interpreting cognitive results. Repeating Mini-ACE after treatment of depression helps distinguish pseudodementia from true cognitive impairment.

Is Mini-ACE validated for non-specialist use?

Yes. Mini-ACE can be administered by trained nurses, GPs, and allied health professionals. Administration does require some training in standard delivery of instructions, clock scoring, and cued recall procedures to ensure reliable results.

What is the minimum clinically important difference on Mini-ACE?

A change of 2-3 points on Mini-ACE is generally considered clinically meaningful for serial monitoring. A drop of 3 or more points between assessments—particularly in address recall or fluency—should prompt comprehensive evaluation.

Online Medical Tools — Mini-ACE

Printed on 9/4/2026

For informational purposes only. This is not medical advice.

Geriatrics

Mini-ACE

Mini-ACE (M-ACE) is a concise 30-point cognitive test derived from the Addenbrooke's Cognitive Examination, designed for rapid outpatient and bedside cognitive triage. It samples multiple cognitive domains and is used to identify patients requiring fuller neurocognitive assessment.

Formula: Mini-ACE total = summed domain points, range 0-30.

Mini-ACE total score

Save your results with a free account

Keep a history of calculations, favorite tools, and access your dashboard anytime.

Create free account Sign in

How It Works

Complete Five Scored Tasks

The examiner administers five tasks: (1) immediate recall of a 7-word address phrase, (2) verbal fluency (animals named in 60 seconds), (3) clock drawing, (4) delayed recall of the address (3 points), and (5) abbreviated cognitive items. Total score 0-30.

Score and Apply the Threshold

Sum item scores. A score of 25 or below is the most widely used threshold for possible cognitive impairment, with reported sensitivity of 88% and specificity of 89% for dementia in published validation studies. Administration takes approximately 5 minutes.

Determine Next Steps

A positive Mini-ACE screen (score <=25) should prompt extended assessment—full ACE-III, MoCA, or formal neuropsychological evaluation—plus collateral history, functional review, and appropriate specialist referral.

Who Uses the Mini-ACE

Rapid Memory Clinic Triage

Memory Clinic Clinicians

Mini-ACE is ideal for memory clinic waiting rooms or pre-appointment triage to identify patients who need full neuropsychological workup. Its 5-minute administration fits naturally into time-constrained memory service workflows.

General Practice Cognitive Screening

General Practitioners & Family Physicians

Use Mini-ACE during annual health checks or in response to patient or carer memory concerns. It provides more cognitive domain coverage than MMSE while remaining brief enough for primary care consultation.

Post-Acute Hospital Assessment

Hospital Geriatric Teams

Administer Mini-ACE as part of post-acute geriatric review to identify cognitive impairment that may affect rehabilitation engagement, discharge planning, and capacity to consent.

Dementia Research Cohorts

Clinical Researchers

Mini-ACE serves as an efficient screening gate in research studies where a time-effective cognitive screen with documented sensitivity and specificity is needed across large participant samples.

Serial Cognitive Monitoring

Outpatient Geriatric & Neurology Clinics

Administer Mini-ACE at 6-12 month intervals to track cognitive trajectory in patients with subjective memory complaints or mild cognitive impairment. Declining scores over time support progressive impairment.

Pro Tips

Verbal Fluency Is Highly Informative

The animal naming fluency item (60 seconds) is one of the most sensitive single items for early dementia. Normal performance is typically 15-18 animals per minute in cognitively intact older adults; fewer than 12 strongly suggests impairment.

Clock Drawing Captures Multiple Domains

The clock drawing subtest reflects executive function, visuospatial ability, and semantic memory simultaneously. Use a standardized scoring criteria—command (draw clock showing 11:10) with a pre-drawn circle provided—and document the specific error types observed.

Delayed Address Recall Is Most Sensitive

The 3-point delayed address recall item is often the single most discriminating item for dementia. Even one uncued recall failure in a patient with concerns warrants follow-up. Offer category cues before scoring failures.

Account for Education and Language

Mini-ACE was validated primarily in English-speaking populations with moderate educational attainment. Apply caution with patients having less than 8 years of formal education or non-native English speakers—borderline scores may reflect language exposure rather than pathology.

Do Not Use as the Sole Diagnostic Instrument

Mini-ACE screens for impairment but cannot characterize dementia subtype, severity stage, or functional impact. Always integrate with clinical history from the patient and an informant before making management decisions.

Fatigue and Anxiety Affect Scores

Test at a time of day when the patient is most alert. Late afternoon testing in older adults may underestimate cognitive reserve. Reassure anxious patients that the test has no pass or fail—this reduces performance anxiety effects.

Compare to Full ACE-III When Borderline

When Mini-ACE scores fall in the 25-27 range with clinical concern, proceed to the full ACE-III which provides 100-point detailed domain scoring across memory, language, attention, fluency, and visuospatial domains.

Document Confounders Systematically

Record depression screen result, medication list (anticholinergics, sedatives), hearing/vision status, and acute illness before interpreting Mini-ACE. These factors can all depress scores independently of neurodegeneration.

Common Questions About Your Results

Evidence-Based Methodology

Mini-ACE has published validation as a practical brief cognitive instrument for impairment detection.

Clinical Content Trust

Last reviewed:: April 21, 2026
Guideline version:: General evidence framework v2026.04
Source set version:: Primary-source set v1

How to Interpret Your Result

Lower Mini-ACE totals indicate stronger cognitive-impairment signal and need for follow-up evaluation.

When to Use This Tool

Use for rapid cognitive triage in clinic or bedside settings when brief multidomain screening is needed.

Limitations

Performance can vary with language, education, sensory impairment, and neurologic comorbidity.

Disclaimer: This tool is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.

Sources

Changelog

April 21, 2026 · trust-baseline
Clinical trust metadata enabled for this tool page with structured review/version fields.

Related Tools